MARKET

DGX

DGX

Quest Diagnostics Inc
NYSE
208.21
-3.31
-1.56%
After Hours: 208.00 -0.21 -0.10% 18:31 07/08 EDT
OPEN
210.74
PREV CLOSE
211.52
HIGH
210.74
LOW
207.23
VOLUME
773.65K
TURNOVER
--
52 WEEK HIGH
218.31
52 WEEK LOW
161.81
MARKET CAP
23.05B
P/E (TTM)
23.02
1D
5D
1M
3M
1Y
5Y
1D
Quest Diagnostics integrates Haystack MRD ctDNA test within OncoEMR
TipRanks · 18h ago
Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
PR Newswire · 19h ago
Digi Power X Provides Operations and Financial Update
Barchart · 2d ago
Reminder - Quest Diagnostics (DGX) Goes Ex-Dividend Soon
NASDAQ · 2d ago
Weekly Report: what happened at DGX last week (0629-0703)?
Weekly Report · 2d ago
Quest Diagnostics (DGX) Could Be 4% Undervalued On Haystack MRD Approval
Simply Wall St · 3d ago
The Week That Was, The Week Ahead: Macro and Markets, July 5
TipRanks · 3d ago
How Investors Are Reacting To Quest Diagnostics (DGX) New MRD Test Milestone And Attunio Partnership
Simply Wall St · 5d ago
More
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. It provides diagnostic insights from the results of its laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and its connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. Its other customers include health plans, employers, emerging retail healthcare providers, government agencies, and others. Its services are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

Webull offers Quest Diagnostics Inc stock information, including NYSE: DGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DGX stock methods without spending real money on the virtual paper trading platform.